PoloniM., NappiG., ArrigoA., SalvoldiF.: “Cerebrospinal fluid 5-Hydroxyindolacetic acid level in migraneus patients during spontaneous attack during headache free period and following treatment with L-tryptophane”. Experimenta1974, 30: 640
3.
SicuteriF.: “5-hydroxytryptophane hypersensitivity as a new theory of headache and central pain: a clinical pharmacological approach with P-chlorphenilalanine”. Psycophamnacology (Beri)1973, 29: 347–357
4.
BoiardiA., CrennaP., MeratiB., NegriS., TansiniE., and BussoneG.: “5-OH-Triptophane in migraine: clinical and neurophysiological considerations”. J. of Neurology1981, 255: 41–46
5.
Bono.: IV Congresso Nazionale della Società Italiana di Farmacologia Clinica. Florence, 1979 26-28 March
6.
SicuteriF.: “5-hydroxytriptophane in the prophilaxis of migraine”. Pharmacological Research Comunications, 1972, Vol. 4, n. 3
7.
HerbergL.J.: “The hypotalamus and aminergic pathways in migraine”. Modern Topics in Migraine, PearceJ. Ed. 1975, Chapter 9, 85–106W. Heicamane Medical Books, London.
